HER2 Protein Overexpression, mRNA Expression, and DNA Amplification Across Solid Tumors: Comparison of Next-Generation Sequencing-Based Assays With Immunohistochemistry.

Nagamine M, Fujisawa T, Sakamoto N, Nakamura Y, Kadowaki S, Ueno M, Boku S, Komatsu Y, Oki E, Makiyama A, Nonomura N, Morizane C, Watari H, Okano S, Iwata H, Namikawa K, Hatanaka Y, Hatanaka KC, Taguchi K, Spetzler D, Radovich M, Magee D, Yoshino T, Oberley M, Kuwata T

Open source

DOI: 10.1200/po-25-00413
Published: 2026 Jan
Container: JCO precision oncology
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1200/po-25-00413,
  title = {HER2 Protein Overexpression, mRNA Expression, and DNA Amplification Across Solid Tumors: Comparison of Next-Generation Sequencing-Based Assays With Immunohistochemistry.},
  author = {Nagamine M and Fujisawa T and Sakamoto N and Nakamura Y and Kadowaki S and Ueno M and Boku S and Komatsu Y and Oki E and Makiyama A and Nonomura N and Morizane C and Watari H and Okano S and Iwata H and Namikawa K and Hatanaka Y and Hatanaka KC and Taguchi K and Spetzler D and Radovich M and Magee D and Yoshino T and Oberley M and Kuwata T},
  year = {2026},
  journal = {JCO precision oncology},
  doi = {10.1200/po-25-00413},
  url = {https://doi.org/10.1200/po-25-00413}
}

RIS

TY  - JOUR
TI  - HER2 Protein Overexpression, mRNA Expression, and DNA Amplification Across Solid Tumors: Comparison of Next-Generation Sequencing-Based Assays With Immunohistochemistry.
AU  - Nagamine M
AU  - Fujisawa T
AU  - Sakamoto N
AU  - Nakamura Y
AU  - Kadowaki S
AU  - Ueno M
AU  - Boku S
AU  - Komatsu Y
AU  - Oki E
AU  - Makiyama A
AU  - Nonomura N
AU  - Morizane C
AU  - Watari H
AU  - Okano S
AU  - Iwata H
AU  - Namikawa K
AU  - Hatanaka Y
AU  - Hatanaka KC
AU  - Taguchi K
AU  - Spetzler D
AU  - Radovich M
AU  - Magee D
AU  - Yoshino T
AU  - Oberley M
AU  - Kuwata T
PY  - 2026
JO  - JCO precision oncology
DO  - 10.1200/po-25-00413
UR  - https://doi.org/10.1200/po-25-00413
ER  -

APA

M, N., T, F., N, S., Y, N., S, K., M, U., S, B., Y, K., E, O., A, M., N, N., C, M., H, W., S, O., H, I., K, N., Y, H., KC, H., K, T., D, S., M, R., D, M., T, Y., M, O., & T, K. (2026). HER2 Protein Overexpression, mRNA Expression, and DNA Amplification Across Solid Tumors: Comparison of Next-Generation Sequencing-Based Assays With Immunohistochemistry.. JCO precision oncology. https://doi.org/10.1200/po-25-00413

Source records

pubmed · retrieved 2026-09-27T11:49:11.482Z